Note: Ingredients listed on restricted chemical lists
General Information
Version
1.0
Revision date
2024-10-14
Product name
OXYPY
1.2.1 Relevant identified uses
Professional use,PT18 - Biocidal products used for the control of arthropods (e.g. insects, arachnids and crustaceans) by means other than repulsion or attraction
supplier name
OXY’PHARM
Emergency telephone
+353 1 809 2566, +353 1 809 2166, +356 2545 6508
Icons in SDS
Company Information
company name
OXY’PHARM
e-mail address of the competent person responsible for the Safety Data Sheet
qualite@oxypharm.net
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H400, H410
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May cause an allergic skin reaction. Very toxic to aquatic life with long lasting effects
Hazard pictograms
GHS07 GHS09
Signal word
Warning
Contains
Chrysanthemum cinerariaefolium extract from open and mature flowers of Tanacetum cinerariifolium obtained with supercritical carbondioxide; Permethrin (ISO)
Hazard statements
H317 - May cause an allergic skin reaction. H400 - Very toxic to aquatic life. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P261 - Avoid breathing vapours. P273 - Avoid release to the environment. P280 - Wear protective gloves, protective clothing, eye protection, face protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P391 - Collect spillage. P501 - Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Other hazards which do not result in classification
None known. To our knowledge, contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Piperonyl butoxide (ISO); 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether (51-03-6), regulation, in accordance with Annex XIII Permethrin (ISO) (52645-53-1) Substance(s) not meeting the vPvB criteria of REACH Piperonyl butoxide (ISO); 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether (51-03-6), regulation, in accordance with Annex XIII Permethrin (ISO) (52645-53-1) To our knowledge, the mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in Permethrin (ISO) (52645-53-1), Piperonyl butoxide (ISO); 2-(2-butoxyethoxy)ethyl 6- accordance with Article 59(1) of REACH for having propylpiperonyl ether (51-03-6), Chrysanthemum cinerariaefolium extract from open and endocrine disrupting properties, or is not identified as mature flowers of Tanacetum cinerariifolium obtained with supercritical carbondioxide having endocrine disrupting properties in accordance (89997-63-7) with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin Sens. 1 H317 Aquatic Acute 1 H400 Aquatic Chronic 1 H410 Full text of hazard classes, H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction. Very toxic to aquatic life with long lasting effects.